Search Results - "Porter, L D"

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia by Kenderian, S S, Ruella, M, Shestova, O, Klichinsky, M, Aikawa, V, Morrissette, J J D, Scholler, J, Song, D, Porter, D L, Carroll, M, June, C H, Gill, S

“…Patients with chemo-refractory acute myeloid leukemia (AML) have a dismal prognosis. Chimeric antigen receptor T (CART) cell therapy has produced exciting…”
Get full text

Metallic fuels for advanced reactors by Carmack, W.J., Porter, D.L., Chang, Y.I., Hayes, S.L., Meyer, M.K., Burkes, D.E., Lee, C.B., Mizuno, T., Delage, F., Somers, J.

“…In the framework of the Generation IV Sodium Fast Reactor Program, the Advanced Fuel Project has conducted an evaluation of the available fuel systems…”
Get full text

Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder by Reshef, R., Vardhanabhuti, S., Luskin, M. R., Heitjan, D. F., Hadjiliadis, D., Goral, S., Krok, K. L., Goldberg, L. R., Porter, D. L., Stadtmauer, E. A., Tsai, D. E.

“…Reduction of immunosuppression (RI) is commonly used to treat posttransplant lymphoproliferative disorder (PTLD) in solid organ transplant recipients. We…”
Get full text

Full-length U–xPu–10Zr (x=0, 8, 19wt.%) fast reactor fuel test in FFTF by Porter, D.L., Tsai, Hanchung

“…The Integral Fast Reactor-1 (IFR-1) experiment performed in the Fast Flux Test Facility (FFTF) was the only U–Pu–10Zr (Pu-0, 8 and 19wt.%) metallic fast…”
Get full text

Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation by Ganetsky, A, Shah, A, Miano, T A, Hwang, W-T, He, J, Loren, A W, Hexner, E O, Frey, N V, Porter, D L, Reshef, R

“…There is significant variability in the serum concentrations of tacrolimus attained early post transplant due to drug interactions and genomic variation. We…”
Get full text

Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation by Loren, A W, Porter, D L

“…Allogeneic stem cell transplantation (SCT) offers the only hope for cure for many adults with acute leukemia. Unfortunately, many patients relapse and die of…”
Get full text

Post-transplant lymphoproliferative disorder: a review by LOREN, A. W, PORTER, D. L, STADTMAUER, E. A, TSAI, D. E

“…Post-transplant lymphoproliferative disorder (PTLD) represents a spectrum of Epstein-Barr virus-related (EBV) clinical diseases, from a benign…”
Get full text

Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma by Olin, R L, Vogl, D T, Porter, D L, Luger, S M, Schuster, S J, Tsai, D E, Siegel, D L, Cook, R J, Mangan, P A, Cunningham, K, Stadtmauer, E A

“…Therapeutic options for patients with multiple myeloma whose disease has relapsed after a prior auto-SCT include novel biologic therapies, traditional…”
Get full text

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation by Collins, Jr, R H, Shpilberg, O, Drobyski, W R, Porter, D L, Giralt, S, Champlin, R, Goodman, S A, Wolff, S N, Hu, W, Verfaillie, C, List, A, Dalton, W, Ognoskie, N, Chetrit, A, Antin, J H, Nemunaitis, J

“…Recipients of allogeneic bone marrow transplants (BMTs) who have relapsed may attain complete remissions when treated with transfusions of leukocytes obtained…”
Get more information

Reduction of FCCI effects in lanthanide–iron diffusion couples by doping with palladium by Egeland, G.W., Mariani, R.D., Hartmann, T., Porter, D.L., Hayes, S.L., Kennedy, J.R.

“…Fast-reactor metallic fuels produce lanthanide fission products which have been shown to diffuse to the fuel periphery. Lanthanides interacting with the…”
Get full text

Association of HLA Polymorphisms with Post‐transplant Lymphoproliferative Disorder in Solid‐Organ Transplant Recipients by Reshef, R., Luskin, M.R., Kamoun, M., Vardhanabhuti, S., Tomaszewski, J. E., Stadtmauer, E. A., Porter, D. L., Heitjan, D. F., Tsai, De. E.

“…The association between HLA polymorphisms and PTLD was investigated in a case–control study, comparing 110 predominantly adult solid‐organ transplant…”
Get full text

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT by Tizon, R, Frey, N, Heitjan, D F, Tan, K S, Goldstein, S C, Hexner, E O, Loren, A, Luger, S M, Reshef, R, Tsai, D, Vogl, D, Davis, J, Vozniak, M, Fuchs, B, Stadtmauer, E A, Porter, D L

“…Idiopathic Pneumonia Syndrome (IPS) is a common complication after allo-SCT and results in high mortality rates. Conventional treatment for IPS typically…”
Get full text

Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas by Paralkar, V R, Nasta, S D, Morrissey, K, Smith, J, Vassilev, P, Martin, M E, Goldstein, S C, Loren, A, Rook, A H, Kim, E J, Porter, D L

“…Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of non-Hodgkin lymphomas that are considered incurable. The role of allogeneic hematopoietic SCT…”
Get full text

Reducing fuel-cladding chemical interaction: The effect of palladium on the reactivity of neodymium on iron in diffusion couples by Egeland, G.W., Mariani, R.D., Hartmann, T., Porter, D.L., Hayes, S.L., Kennedy, J.R.

“…Fast-reactor fuel alloys produce lanthanide fission products which migrate to the fuel/cladding interface causing fuel-cladding chemical interaction. To test…”
Get full text

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation by SVOBODA, J, ANDREADIS, C, LOREN, A. W, SIEGEL, D. L, GLATSTEIN, E, ALAVI, A, STADTMAUER, E. A, SCHUSTER, S. J, ELSTROM, R, CHONG, E. A, DOWNS, L. H, BERKOWITZ, A, LUGER, S. M, PORTER, D. L, NASTA, S, TSAI, D

“…We conducted a retrospective analysis of 50 lymphoma patients (Hodgkin's disease and non-Hodgkin's lymphoma) who had an 18F-fluoro-deoxyglucose positron…”
Get full text

Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD by Rager, A, Frey, N, Goldstein, S C, Reshef, R, Hexner, E O, Loren, A, Luger, S M, Perl, A, Tsai, D, Davis, J, Vozniak, M, Smith, J, Stadtmauer, E A, Porter, D L

“…Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-α are important mediators…”
Get full text

Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen by Nazha, A, Cook, R, Vogl, D T, Mangan, P A, Gardler, M, Hummel, K, Cunningham, K, Luger, S M, Porter, D L, Schuster, S, O'Doherty, U, Siegel, D, Stadtmauer, E A

“…Lenalidomide is an active treatment for multiple myeloma (MM) and is increasingly used as part of the initial treatment of this disease. Recent reports have…”
Get full text

Resistance of peas to Sclerotinia sclerotiorum in the Pisum core collection by Porter, L.D, Hoheisel, G, Coffman, V.A

“…In this study, 497 pea accessions from the Pisum core collection located at the USDA-ARS, Western Regional Plant Introduction Station (WRPIS), Pullman, WA and…”
Get full text

Early Influences of Microbiota on White Matter Development in Germ-Free Piglets by Ahmed, Sadia, Travis, Sierrah D, Díaz-Bahamonde, Francisca V, Porter, Demisha D L, Henry, Sara N, Mykins, Julia, Ravipati, Aditya, Booker, Aryn, Ju, Jing, Ding, Hanzhang, Ramesh, Ashwin K, Pickrell, Alicia M, Wang, Maosen, LaConte, Stephen, Howell, Brittany R, Yuan, Lijuan, Morton, Paul D

“…Abnormalities in the prefrontal cortex (PFC), as well as the underlying white matter (WM) tracts, lie at the intersection of many neurodevelopmental disorders…”
Get full text

Identification of novel sources of resistance to Pea enation mosaic virus in chickpea germplasm by Larsen, R.C, Porter, L.D

“…Chickpea can be seriously affected by Pea enation mosaic virus (PEMV) in the Pacific Northwest region of the USA and other areas of the world. Use of…”
Get full text